United States · Nanobiotechnology · Reviewed 2026-10-15

Dr. Shree R. Singh

Dr. Singh directs the multi-million dollar NSF CREST center at ASU, pioneering nanoparticle-based vaccine adjuvants and antiviral therapies against respiratory syncytial virus.

Official faculty profile ↗Research checked, not sponsored

Documented research interests and leadership

Research areas: Nanobiotechnology, Respiratory Syncytial Virus (RSV), Nanoparticle Drug Delivery, Antimicrobial Peptide Nanotubes
Academic position: Professor of Microbiology & Director of Center for Nanobiotechnology Research
Primary university source: Official directory entry ↗
Recruitment status: Not verified. Leadership profile does not imply active vacancies or assistantship availability.

Supervision and contact

Students interested in graduate or doctoral research supervision in Nanobiotechnology, Respiratory Syncytial Virus (RSV), Nanoparticle Drug Delivery are advised to consult formal department application channels.

ASU guide ↗Biology subject guide ↗Mentorship ↗

Important verification note

Facts reflect official university directory records reviewed 2026-10-15. Faculty recruitment and admissions require formal application.

Reviewed 2026-10-15 · Editorial standards · Report an issue